FDA
approval
· 2022-12-21
FDA Approved: DOBUTAMINE — Original Application (Slate Run Pharmaceuticals)
Summary
FDA approves Slate Run Pharmaceuticals' dobutamine—Original Application (ANDA 216131)—granting approval of a generic dobutamine product. This action expands acc…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DOBUTAMINE (DOBUTAMINE)